Partnered Content
Pharma Ignite (Citeline’s marketing insights division), brings together a network of 400+ industry analysts, editors, marketers, and our clients to deliver fresh content, insights and establish connections between clients and pharma’s leaders. Armed with Citeline’s subscribers and solutions including Scrip, Pink Sheet, In Vivo, Generics Bulletin and Medtech Insights, leverage our industry knowledge to build brand credibility, generate leads and create thought leadership and engaging content. Click here to find out more on our award-winning marketing solutions.
Whitepaper
Upcoming Events
The Enterprise AI Capability Gap
More Impact, Less Admin with Agentic AI
More Impact, Less Admin with Agentic AI
Research Reports
The article discusses the impact of upcoming patent expirations in oncology biologics on biosimilar developers, highlighting the opportunities in Antibody-Drug Conjugates (ADCs) and Bispecific Antibodies (BsAbs). It explores the challenges posed by the structural complexities of these biologics, necessitating new bioanalytical tools and manufacturing processes. The evolving regulatory landscape, with contributions from EMA, FDA, and WHO, offers flexible pathways but also presents challenges. The article underscores the potential for biosimilars to generate significant cost savings and enhance patient access to cancer treatments over the next decade.
To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.
To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.
Podcasts
Discover what’s on the horizon for the pharma industry as truly transformative technologies revolutionize the way drugs are developed, delivered and manufactured.
More than 100 biopharma executives and experts told Scrip their predictions for therapeutic area advances in the coming year. The recent commercial success of GLP-1s in diabetes and obesity and their potential in further disease areas fuelled excitement around the metabolic space. Expectations were also positive in neurology following the launch of Leqembi for Alzheimer’s disease in 2023, while the multiple opportunities to improve cancer treatment kept oncology top of the pile overall.
Some 50 experts and executives in the biopharma sector shared their views on the major trends they expect to see driving change in the clinical trials arena in 2024. Artificial intelligence applied to clinical development, greater use of remote monitoring and increased patient diversity in trials were key themes.
More than 75 industry executives and experts gazed into the crystal ball and shared with Scrip their predictions around transformative technologies. Perhaps unsurprisingly, AI was the dominant theme – but gene editing, cell therapies and new targeting modalities were also among the highlights.
Roundtable Reports
As clinical trials grow more complex, execution pressures are changing where and how evidence is collected.
To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.
Upcoming Webinar
- From Global to China, From China to Global: Rethinking Cross-Border Drug Development
In partnership with Tigermed
- The State of Materiovigilance: New Survey Insights on Combination Device Safety
In partnership with IQVIA
- The ‘Step 0’ Imperative: Why Brilliant Science Is Failing at Launch
In partnership with Lucid Group
- Smarter Molecular Strategies for Infectious Disease Trials: Turning Complex Data into Clinical Advantage
In partnership with hVivo
- Fast-Tracking First-In-Human: A Startup-Focused Guide to IND Readiness and Early Clinical Success
In partnership with hVivo
- Making the Right Decisions With Incomplete Evidence in Early-Phase Oncology Trials
In partnership with MMS
- Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy
In partnership with Certara
- Driving Consistency & Confidence Through Standardized qPCR Analytics for Cell Therapy Translation
In partnership with Thermo Fisher
- Beyond Solid Phase Synthesis: Driving TIDES Process and Process Development Faster, Better, and More Sustainable
In partnership with Asymchem
- Integrated CMC-Based Pharmaceutical Development - Accelerating The Molecule To FIH
In partnership with Syngene
- Delivering What Matters: Rethinking Clinical Trial Logistics for a Global Stage
In partnership with Thermo Fisher
- Lachman FOCUS Series: Quality Operations in the Era of Digital Transformation
In partnership with Lachman
- A Practical Guide to Expedited Regulatory Pathways
In partnership with MMS
- Faster Trials, Programmatic Scale: Standardizing a Digital Approach Across Therapeutic Areas
In partnership with Medable
- Turning EHR Data Into Device Market Advantage
In partnership with Truveta
- Scaling Smart: Overcoming the Top Roadblocks in Biologic Drug Manufacturing
In partnership with Thermo Fisher
- Lifting Australian Oncology Clinical Trials To The Next Level
In partnership with Souther Star Research
- Enhancing Aspetic Fill Finish Processes with Advanced Solutions
In partnership with Thermo Fisher
- Improving Patient Health and Safety Through Pharmacovigilance and Medical Information Synergy
In partnership with ProPharma
- Injectable Formulation Development: Technical Strategies for Early-Phase Programs
In partnership with Thermo Fisher
- The VIP Assist: Discovering Process Pitfalls and Hindsight
In partnership with MDDAP, LLC
- Speed, security, success: Innovations in cold chain packaging and labeling for clinical trials
In partnership with Thermo Fisher Scientific
- Industry Outlook: Benchmarking Biopharma’s Next Wave of Clinical Data Transformation
In partnership with eClinical Solutions
- Stop outsourcing, start partnering: Redefining value in global clinical trial execution
In partnership with Thermo Fisher Scientific
- Beyond development: Using continuous manufacturing to accelerate OSD commercialization
In partnership with Thermo Fisher Scientific
- De-Risking Development with Specialized Data Strategies - From Trial Design to Submission
In partnership with MMS Holdings
- Delivering Value in Clinical Trial Logistics: Managing Complexity, Accelerating Timelines, and Embracing Innovation
In partnership with Thermo Fisher Scientific
Webinar Executive Summaries
Over 30 documents have been posted on the tracker since its last update.
eBooks
White Papers
Partnered Content features stories created in collaboration with our trusted brand partners. This section showcases content produced together with select partners to bring added insights to our readers.
The article discusses the impact of upcoming patent expirations in oncology biologics on biosimilar developers, highlighting the opportunities in Antibody-Drug Conjugates (ADCs) and Bispecific Antibodies (BsAbs). It explores the challenges posed by the structural complexities of these biologics, necessitating new bioanalytical tools and manufacturing processes. The evolving regulatory landscape, with contributions from EMA, FDA, and WHO, offers flexible pathways but also presents challenges. The article underscores the potential for biosimilars to generate significant cost savings and enhance patient access to cancer treatments over the next decade.
To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.
Infographics
As clinical trials grow more complex, execution pressures are changing where and how evidence is collected.
Infographics Test
As clinical trials grow more complex, execution pressures are changing where and how evidence is collected.
Partnered Content features stories created in collaboration with our trusted brand partners. This section showcases content produced together with select partners to bring added insights to our readers.